Estimating a treatment effect with the accelerated hazards models

Controlled Clinical Trials

Volumn 21, Issue 4, 2000, Pages 369-380

  Chen, Ying Qing ^a   Wang, Mei Cheng ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Johns H   (United States)

Author keywords

Accelerated failure time model; Hazard function; Proportional hazards model; Randomized clinical trials; Regression models; Scale change; Survival time

Indexed keywords

CARMUSTINE; PLACEBO; POLYMER;

ARTICLE; BIODEGRADATION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLIOBLASTOMA; HAZARD; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; RANDOMIZED CONTROLLED TRIAL; STATISTICAL CONCEPTS; STATISTICAL MODEL; SURVIVAL; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; CLINICAL TRIALS; GLIOMA; HUMANS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033920290     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(00)00063-5     Document Type: Article

References (14)

1. Brem H., Piantadosi S., Burger P.C.et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet. 345:1995;1008-1012.
2. Cox D.R. Regression models and life-tables (with discussion). J Roy Stat Soc Series B. 34:1972;187-220.
3. Kalbfleisch J.D., Prentice R.L. The Statistical Analysis of Failure Time Data. 1980;Wiley, New York.
4. Louis T. Nonparametric analysis of an accelerated failure time model. Biometrika. 68:1981;381-390.
5. Wei L.J., Gail M.H. Nonparametric estimation for a scale-change with censored observation. J Am Stat Assoc. 78:1983;382-388.
6. Chen Y.Q., Wang M.C. Analysis of accelerated hazards model. J Am Stat Assoc. 95:2000;608-618.
7. Fleming T.R., Harrington D.P. Counting Processes and Survival Analysis. 1991;Wiley, New York.
8. Piantadosi S. Clinical Trials. A Methodological Perspective:1997;Wiley, New York.
9. Tamargo R.J., Myseros J.S., Epstein J.I.et al. Interstitial chemotherapy of the 9L gliosarcoma. Controlled release polymers for drug delivery in the brain Cancer Res. 53:1993;329-333.
10. Breslow N.E., Day N.E. Statistical Methods in Cancer Research (II). The Design and Analysis of Cohort Studies:1987;Oxford University Press, New York.
11. Miller R.G. Survival Analysis. 1981;Wiley, New York.
12. Chen YQ, Jewell, NP. On a general class of hazards regression models. Technical Report. Berkeley, California: UC Berkeley School of Public Health, Division of Biostatistics. 2000;83.
13. Chen YQ. Assessing adequacy of a class of semiparametric hazards regression models. Technical Report. Berkeley, California: UC Berkeley School of Public Health, Division of Biostatistics. 1999;80.
14. Tsiatis A.A. Estimating regression parameters using linear rank tests for censored data. Ann Stat. 18:1990;354-372.